tirzepatide pancreatitis risk alcohol GLP-1 Agonists and Pancreatitis in Patients Receiving Tirzepatide
Description
doi: 10.1080/AC.70.1.3064591 24 ScaglioneRArganoCDi ChiaraTColombaDParrinelloGCorraoSet al

I received my meds on time and packaged very nicely (with the meds packed in a cold pack and still cold)

We are happy to facilitate requests for a release of your medical records with Felix to your primary care provider

It encourages the pancreas to release insulin when blood sugar is high and reduces the production of glucagon, a hormone that raises blood sugar

It acts on three hormone pathways: GIP, GLP-1, and glucagon

The key takeaway: occasional two-day-early dosing is pharmacologically tolerable, but it should not become your regular pattern
